Hydroxychlorokin behandling forårsager sjældent øjenskader når det anvendes korrekt

Anne Troldborg, Trine Bay-Laurberg, Kåre Clemmensen, Jeanette Andersen, Bent Deleuran

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Abstract

Hydroxychloroquine (HCQ) is used in the treatment of rheumatologic diseases including systemic lupus erythematosus, rheumatoid arthritis and other conditions. Besides reducing joint and skin inflammation, growing evidence shows other beneficial effects of HCQ, e.g. a positive effect on cardiovascular risk, pregnancy outcome, and flare reduction. In this review, we wish to emphasise "best practice" in the use of HCQ based on the present literature, to show the typical eye damage, which may occur, and to highlight which precautions should be made, so that retinal injury does not occur.

Bidragets oversatte titelHydroxychloroquine treatment rarely causes eye damage when used correctly
OriginalsprogDansk
TidsskriftUgeskrift for Læger
Vol/bind182
Nummer32
ISSN0041-5782
StatusUdgivet - 3 aug. 2020

Emneord

  • Antirheumatic Agents/therapeutic use
  • Arthritis, Rheumatoid/drug therapy
  • Female
  • Humans
  • Hydroxychloroquine/adverse effects
  • Lupus Erythematosus, Systemic/drug therapy
  • Pregnancy
  • Retinal Diseases/prevention & control

Fingeraftryk

Dyk ned i forskningsemnerne om 'Hydroxychlorokin behandling forårsager sjældent øjenskader når det anvendes korrekt'. Sammen danner de et unikt fingeraftryk.

Citationsformater